Updated:
Chromatin
Chromatin is a Chicago-based company founded in 2001. It develops hybrid sorghum seeds for agricultural markets and has secured $96,199,998 in total funding.
Chromatin
Chromatin is a Chicago-based company founded in 2001. It develops hybrid sorghum seeds for agricultural markets and has secured $96,199,998 in total funding.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Chicago
Corporate office
Chicago, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Chromatin?
Chromatin does not publicly identify any named principals, investment committee members, or CIO on its website or in any external sources. The firm's editorial content is published under a generic 'Future Food' brand without bylines, making it impossible to attribute decision-making authority to any individual (per the firm's website, 2025).
What investment stages does Chromatin typically target?
Chromatin does not disclose any investment stage preferences, target tick sizes, or deal structures. Its public content focuses exclusively on plant-breeding research and commentary on geopolitical food-security issues. Without named portfolio companies or funding announcements, no stage or capital-market role can be inferred (per the firm's website, 2025).
Which sectors does Chromatin focus on?
Chromatin's published research and editorial coverage concentrate on cereal crop breeding — specifically maize, wheat, and grain sorghum. The firm's content often links these crop genetics to broader themes of global food security, climate resilience, and national security. No additional sectors such as fintech, healthcare, or real estate are mentioned on its website (per the firm's website, 2025).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: